Dong Wha Goes Global with P&G
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 86 (Table of Contents)
Published: 7 Aug-2007
DOI: 10.3833/pdr.v2007.i86.308 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Dong Wha Pharmaceutical Industrial has agreed to assign the ex-Asian rights for a class of osteoporosis drugs including a lead compound DW-1350 developed by Procter & Gamble Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS